183 related articles for article (PubMed ID: 28298295)
21. Mineralocorticoid receptor activation: a major contributor to salt-induced renal injury and hypertension in young rats.
Kawarazaki H; Ando K; Fujita M; Matsui H; Nagae A; Muraoka K; Kawarasaki C; Fujita T
Am J Physiol Renal Physiol; 2011 Jun; 300(6):F1402-9. PubMed ID: 21478481
[TBL] [Abstract][Full Text] [Related]
22. CD70 Exacerbates Blood Pressure Elevation and Renal Damage in Response to Repeated Hypertensive Stimuli.
Itani HA; Xiao L; Saleh MA; Wu J; Pilkinton MA; Dale BL; Barbaro NR; Foss JD; Kirabo A; Montaniel KR; Norlander AE; Chen W; Sato R; Navar LG; Mallal SA; Madhur MS; Bernstein KE; Harrison DG
Circ Res; 2016 Apr; 118(8):1233-43. PubMed ID: 26988069
[TBL] [Abstract][Full Text] [Related]
23. The endothelial mineralocorticoid receptor regulates vasoconstrictor tone and blood pressure.
Nguyen Dinh Cat A; Griol-Charhbili V; Loufrani L; Labat C; Benjamin L; Farman N; Lacolley P; Henrion D; Jaisser F
FASEB J; 2010 Jul; 24(7):2454-63. PubMed ID: 20299606
[TBL] [Abstract][Full Text] [Related]
24. Adipocyte-derived factors regulate vascular smooth muscle cells through mineralocorticoid and glucocorticoid receptors.
Nguyen Dinh Cat A; Briones AM; Callera GE; Yogi A; He Y; Montezano AC; Touyz RM
Hypertension; 2011 Sep; 58(3):479-88. PubMed ID: 21788604
[TBL] [Abstract][Full Text] [Related]
25. The mineralocorticoid receptor blocker spironolactone lowers plasma interferon-γ and interleukin-6 in patients with type 2 diabetes and treatment-resistant hypertension.
Thangaraj SS; Oxlund CS; Fonseca MPD; Svenningsen P; Stubbe J; Palarasah Y; Ketelhuth DFJ; Jacobsen IA; Jensen BL
J Hypertens; 2022 Jan; 40(1):153-162. PubMed ID: 34843183
[TBL] [Abstract][Full Text] [Related]
26. A New Role of Mister (MR) T in Hypertension: Mineralocorticoid Receptor, Immune System, and Hypertension.
Barbaro NR; Kirabo A; Harrison DG
Circ Res; 2017 May; 120(10):1527-1529. PubMed ID: 28495982
[No Abstract] [Full Text] [Related]
27. Atrial natriuretic peptide locally counteracts the deleterious effects of cardiomyocyte mineralocorticoid receptor activation.
Nakagawa H; Oberwinkler H; Nikolaev VO; Gaßner B; Umbenhauer S; Wagner H; Saito Y; Baba HA; Frantz S; Kuhn M
Circ Heart Fail; 2014 Sep; 7(5):814-21. PubMed ID: 25027872
[TBL] [Abstract][Full Text] [Related]
28. Role of brain aldosterone and mineralocorticoid receptors in aldosterone-salt hypertension in rats.
Wang HW; Huang BS; Chen A; Ahmad M; White RA; Leenen FH
Neuroscience; 2016 Feb; 314():90-105. PubMed ID: 26656220
[TBL] [Abstract][Full Text] [Related]
29. Deoxycorticosterone Acetate/Salt-Induced Cardiac But Not Renal Injury Is Mediated By Endothelial Mineralocorticoid Receptors Independently From Blood Pressure.
Lother A; Fürst D; Bergemann S; Gilsbach R; Grahammer F; Huber TB; Hilgendorf I; Bode C; Moser M; Hein L
Hypertension; 2016 Jan; 67(1):130-8. PubMed ID: 26553231
[TBL] [Abstract][Full Text] [Related]
30. Mineralocorticoid Receptor Deficiency in Macrophages Inhibits Neointimal Hyperplasia and Suppresses Macrophage Inflammation Through SGK1-AP1/NF-κB Pathways.
Sun JY; Li C; Shen ZX; Zhang WC; Ai TJ; Du LJ; Zhang YY; Yao GF; Liu Y; Sun S; Naray-Fejes-Toth A; Fejes-Toth G; Peng Y; Chen M; Liu X; Tao J; Zhou B; Yu Y; Guo F; Du J; Duan SZ
Arterioscler Thromb Vasc Biol; 2016 May; 36(5):874-85. PubMed ID: 26966277
[TBL] [Abstract][Full Text] [Related]
31. Lymphocyte adaptor protein LNK deficiency exacerbates hypertension and end-organ inflammation.
Saleh MA; McMaster WG; Wu J; Norlander AE; Funt SA; Thabet SR; Kirabo A; Xiao L; Chen W; Itani HA; Michell D; Huan T; Zhang Y; Takaki S; Titze J; Levy D; Harrison DG; Madhur MS
J Clin Invest; 2015 Mar; 125(3):1189-202. PubMed ID: 25664851
[TBL] [Abstract][Full Text] [Related]
32. Myeloid mineralocorticoid receptor controls macrophage polarization and cardiovascular hypertrophy and remodeling in mice.
Usher MG; Duan SZ; Ivaschenko CY; Frieler RA; Berger S; Schütz G; Lumeng CN; Mortensen RM
J Clin Invest; 2010 Sep; 120(9):3350-64. PubMed ID: 20697155
[TBL] [Abstract][Full Text] [Related]
33. A Single Nucleotide Polymorphism in
Alexander MR; Hank S; Dale BL; Himmel L; Zhong X; Smart CD; Fehrenbach DJ; Chen Y; Prabakaran N; Tirado B; Centrella M; Ao M; Du L; Shyr Y; Levy D; Madhur MS
Circ Res; 2022 Oct; 131(9):731-747. PubMed ID: 36169218
[TBL] [Abstract][Full Text] [Related]
34. Interferon-γ signaling inhibition ameliorates angiotensin II-induced cardiac damage.
Markó L; Kvakan H; Park JK; Qadri F; Spallek B; Binger KJ; Bowman EP; Kleinewietfeld M; Fokuhl V; Dechend R; Müller DN
Hypertension; 2012 Dec; 60(6):1430-6. PubMed ID: 23108651
[TBL] [Abstract][Full Text] [Related]
35. T-cell-mediated regulation of osteoclastogenesis by signalling cross-talk between RANKL and IFN-gamma.
Takayanagi H; Ogasawara K; Hida S; Chiba T; Murata S; Sato K; Takaoka A; Yokochi T; Oda H; Tanaka K; Nakamura K; Taniguchi T
Nature; 2000 Nov; 408(6812):600-5. PubMed ID: 11117749
[TBL] [Abstract][Full Text] [Related]
36. Direct contribution of vascular mineralocorticoid receptors to blood pressure regulation.
Barrett KV; McCurley AT; Jaffe IZ
Clin Exp Pharmacol Physiol; 2013 Dec; 40(12):902-9. PubMed ID: 23710823
[TBL] [Abstract][Full Text] [Related]
37. Role of brain corticosterone and aldosterone in central angiotensin II-induced hypertension.
Huang BS; White RA; Ahmad M; Leenen FH
Hypertension; 2013 Sep; 62(3):564-71. PubMed ID: 23856493
[TBL] [Abstract][Full Text] [Related]
38. Interferon-gamma regulates idiopathic pneumonia syndrome, a Th17+CD4+ T-cell-mediated graft-versus-host disease.
Mauermann N; Burian J; von Garnier C; Dirnhofer S; Germano D; Schuett C; Tamm M; Bingisser R; Eriksson U; Hunziker L
Am J Respir Crit Care Med; 2008 Aug; 178(4):379-88. PubMed ID: 18511701
[TBL] [Abstract][Full Text] [Related]
39. Paradoxical mineralocorticoid receptor activation and left ventricular diastolic dysfunction under high oxidative stress conditions.
Wang H; Shimosawa T; Matsui H; Kaneko T; Ogura S; Uetake Y; Takenaka K; Yatomi Y; Fujita T
J Hypertens; 2008 Jul; 26(7):1453-62. PubMed ID: 18551023
[TBL] [Abstract][Full Text] [Related]
40. Collecting duct prorenin receptor knockout reduces renal function, increases sodium excretion, and mitigates renal responses in ANG II-induced hypertensive mice.
Prieto MC; Reverte V; Mamenko M; Kuczeriszka M; Veiras LC; Rosales CB; McLellan M; Gentile O; Jensen VB; Ichihara A; McDonough AA; Pochynyuk OM; Gonzalez AA
Am J Physiol Renal Physiol; 2017 Dec; 313(6):F1243-F1253. PubMed ID: 28814438
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
